A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
Trial details
- Registry ID
- NCT05712356
- Phase
- Phase 2
The FDA approved Cisplatin on 19 Dec 1978.
Drug identity checked against registry records
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 1978-12-19Day | Cisplatin | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA018057", "applicant_as_listed_by_fda": "HQ SPCLT PHARMA", "brand_names": ["CISPLATIN", "PLATINOL", "PLATINOL-AQ"], "active_ingredients": ["CISPLATIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19781219", "matched_on": "drug name equals FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |